PMID- 14617033 OWN - NLM STAT- MEDLINE DCOM- 20040722 LR - 20190827 IS - 0001-2815 (Print) IS - 0001-2815 (Linking) VI - 62 IP - 6 DP - 2003 Dec TI - Single-nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. PG - 498-504 AB - Rheumatoid arthritis (RA) is a chronic arthritic condition that can lead to deformities and disabilities. Although numerous studies reported the association of human leukocyte antigen (HLA)-DRB1*04 and RA, other genes, e.g. cytokines genes, may contribute towards disease susceptibility. Interleukin-18 (IL-18) is a proinflammatory cytokine postulated to play a role in the acute and chronic inflammatory phases of RA. The IL-18 protein expression seems to be regulated by two single-nucleotide polymorphisms (SNPs) located at positions -607 and -137 in the promoter region of the gene. It is postulated that specific alleles may be associated with susceptibility to the development of RA. In the present study, we described the IL-18 gene promoter region genotypes and combined genotypes (-607/-137) in 106 RA patients and 273 unrelated healthy controls to evaluate the contributions of these alleles to RA predisposition in Chinese, Malays, and Indians. The genotyping were performed using sequence-specific polymerase chain reactions. Rheumatoid factors were assayed by enzyme-linked immunosorbent assay. Biodata were obtained through chart review. The controls had significantly higher frequency of AA genotype at position -607 when compared to RA patients. No significant differences were observed in the distribution of either allelic or genotypic frequencies at position -137. There was no association between the genotypes and the presence of rheumatoid factors. This study did not find evidence of a genetic susceptibility factor but demonstrated the novel finding that the AA genotype at position -607 is associated with a protective effect against development of RA in Chinese individuals. This protection may be mediated through inhibition of cyclic (Adenosine 3', 5'-cyclic monophosphate) AMP-responsive element (CRE)-binding protein by the disruption of the CRE consensus sequence. FAU - Sivalingam, S P AU - Sivalingam SP AD - Department of Medicine, National University of Singapore, Singapore Department of Physiology, National University of Singapore, Singapore. FAU - Yoon, K H AU - Yoon KH FAU - Koh, D R AU - Koh DR FAU - Fong, K Y AU - Fong KY LA - eng PT - Journal Article PL - England TA - Tissue Antigens JT - Tissue antigens JID - 0331072 RN - 0 (Interleukin-18) RN - 9009-79-4 (Rheumatoid Factor) SB - IM MH - Adult MH - Arthritis, Rheumatoid/ethnology/*genetics MH - Case-Control Studies MH - China/ethnology MH - Female MH - Gene Frequency MH - Genotype MH - Humans MH - India/ethnology MH - Interleukin-18/*genetics MH - Malaysia/ethnology MH - Male MH - Middle Aged MH - *Polymorphism, Single Nucleotide MH - *Promoter Regions, Genetic MH - Rheumatoid Factor EDAT- 2003/11/18 05:00 MHDA- 2004/07/23 05:00 CRDT- 2003/11/18 05:00 PHST- 2003/11/18 05:00 [pubmed] PHST- 2004/07/23 05:00 [medline] PHST- 2003/11/18 05:00 [entrez] AID - 137 [pii] AID - 10.1046/j.1399-0039.2003.00137.x [doi] PST - ppublish SO - Tissue Antigens. 2003 Dec;62(6):498-504. doi: 10.1046/j.1399-0039.2003.00137.x.